Course Director Dr Mayer developed the Master Class for Oncologists curriculum in collaboration with colleagues from Dana-Farber Cancer Institute and other institutions of excellence. The expert faculty will present the latest advances in genetics, clinical pharmacology, epidemiology, and supportive care – new approaches that can be applied to your oncology practice.

Create an online account to receive updates on new activities and events, and access your CME Tracker.

Note: Fields with * are required

Additional Resources

The course syllabus will be available to download 1 week before the courses in Dallas, TX and Chicago, IL. Past syllabi are also available; you must have registered for the courses in Pasadena, CA and New York, NY and be logged in to your Pri-Med account to download the presentations.

My CME Planner

When your certificates are available, we will email you a link to your My CME Planner. You can download your certificate, track all your credits earned, and print a summary of your credits and certificates. Log in to My CME planner.

These activities are sponsored by pmiCME. For a complete listing of CME credits, please refer to the accreditation and designation statement in each individual activity.

Support for these activities has been provided by: Eli Lilly and Company, Celgene Corporation, AstraZeneca, Millennium, The Takeda Oncology, Genentech, and Bristol-Myers Squibb Company.

© 2010 M|C Communications, LLC. All other trademarks are the property of their respective owners.

For details on Pri-Med's cancellation policy, visit www.pri-med.com/cancel

Each track features interactive, case-based sessions and many opportunities for faculty and audience interaction, question, and answer sessions, and panel discussions to put the latest data into the context of clinical practice.

Sample the Master Class curriculum by taking tuition-free, online CME complementary to the program
Look for the for recommendations.

GASTROINTESTINAL CANCER TRACK
TRACK DIRECTOR: Robert J. Mayer, MD
Genetic Syndromes and Gastrointestinal Cancers: A Practical Guide to Identifying and Managing Patients at Risk
Sapna Syngal, MD, MPH Dana-Farber Cancer Institute Brigham and Women's Hospital
Gastrointestinal Cancers and the Risk of Recurrence: Patient Lifestyle Changes that Make a Difference
Charles S. Fuchs, MD, MPH Dana-Farber Cancer Institute
Systemic Treatment for Colorectal Cancer in 2010
Robert J. Mayer, MD Dana-Farber Cancer Institute
Multimodal Strategies for Esophageal, Gastric and Pancreatic Cancers: Update on Clinical Trial Results and Current Best Practices
Peter C. Enzinger, MD Dana-Farber Cancer Institute

Dr. Venook's Webcast: Pancreatic and Hepatobiliary Cancers: Progress at Last?
Dr. Syngal's Expert Perspective: Hereditary Gastrointestinal Cancers: Insights Into Management for the Practicing Oncologist

BREAST CANCER CANCER TRACK
TRACK DIRECTOR: Harold J. Burstein, MD, PhD
Breast Cancer and Genetics: A Practical Guide to Identifying and Managing High-Risk Patients
Judy E. Garber, MD, MPH Dana-Farber Cancer Institute
Kenneth Offit, MD, MPH Memorial Sloan-Kettering Cancer Center
Her2+ and Triple Negative Breast Cancer
Eric P. Winer, MD Dana-Farber Cancer Institute
Hormone Receptor Positive Breast Cancer: Best Management Practices for Long-Term Therapy
Harold J. Burstein, MD, PhD Dana-Farber Cancer Institute
Interactive Discussion on Breast Cancer Survivorship: Optimizing Patient Outcomes by Incorporating Recent Expert Guidelines into Everyday Practice
Ann H. Partridge, MD, MPH Dana-Farber Cancer Institute

Dr. Garber's Expert Perspective: Breast and Ovarian Cancer Genetics: Current Status and Future Directions

HEMATOLOGIC MALIGNANCIES TRACK
TRACK DIRECTOR: Arnold S. Freedman, MD
Treating Aggressive Lymphomas: Clinical Insights into Challenging Cases
Arnold S. Freedman, MD Dana-Farber Cancer Institute
Update on Myeloid Malignancies: Incorporating New Strategies into Current Management Paradigms
Richard M. Stone, MD Dana-Farber Cancer Institute
Best Practices in Myeloproliferative Neoplasms: Diagnosis, Treatment Goals and Effective Therapeutic Choices
Ayalew Tefferi, MD Mayo Medical School
Multiple Myeloma: Continuing Evolution of the Clinical Landscape
Kenneth C. Anderson, MD Dana-Farber Cancer Institute
Chronic Lymphocytic Leukemia: Molecular Insights, Prognostic Factors, and Therapeutic Advances
John C. Byrd, MD Ohio State University

Dr. Anderson's Webcast: Multiple Myeloma: Current Treatment Paradigms and Future Directions
Dr. DeAngelo's Expert Perspective: Chronic Myelocytic Leukemia: Imatinib and Beyond

LUNG, HEAD AND NECK CANCERS TRACK
TRACK DIRECTOR: Bruce E. Johnson, MD
Small Cell Lung Cancer: Best Practices and Recent Advances
Bruce E. Johnson, MD Dana-Farber Cancer Institute
Non-Small Cell Lung Cancer: Molecular Insights and New Treatment Paradigms for Unique/Specific Cases
Pasi A. Jänne, MD, PhD Dana-Farber Cancer Institute
Head and Neck Cancer Update: Combined Treatment Modalities and Comprehensive Management
Robert I. Haddad, MD Dana-Farber Cancer Institute
David G. Pfister, MD Memorial Sloan-Kettering Cancer Center

Dr. Janne's Webast: Improved Strategies for Relapsed NSCLC: New Regimens, New Combinations, and Targeted Therapies
Dr. Kris' Expert Perspective: Personalizing the Initial Therapy of Advanced Non-Small-Cell Lung Cancer (NSCLC)


SUPPORTIVE CARE SESSION
Caring for the Whole Patient: Supportive Care that Optimizes Treatment of the Physical, Psychological and Social Consequences of Cancer
Janet Abrahm, MD Dana-Farber Cancer Institute

GENITOURINARY CANCER SESSION
Advanced and Metastatic Prostate Cancer: Patient Assessment and Current Best Practices and Emerging Therapies
Philip Kantoff, MD Dana-Farber Cancer Institute
 
© Copyright 2010 Dana-Farber Cancer Institute. All rights reserved. Pri-Med Institute is a registered trademark of M|C Communications, LLC. All other trademarks are property of their respective owners